BrachySource™ 1251CSRRecalls & reported problems
Bard Brachytherapy, Inc. · BrachySource™ I-125 Implant Seed in Cartridges · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00801741078262), received between May 3, 2018 and Mar 15, 2019 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Inadequate Instructions for Healthcare Professional” (2 reports).
1 other recall cover devices cleared under the same FDA submission (K093663); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Inadequate Instructions for Healthcare Professional2
- Incorrect Device Or Component Shipped1
Patient problems
- No Consequences Or Impact To Patient2
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 15, 2019Inadequate Instructions for Healthcare Professional; Inadequate Instructions for Healthcare Professional
IT WAS REPORTED THAT THE SEEDS WERE SHIPPED TO SURGERY FOR UROLOGY IN (B)(6) INSTEAD OF (B)(6) MEDICAL CENTER IN (B)(6). THE SEEDS HAD TO BE DRIVEN TO (B)(6) MEDICAL CENTER FROM (B)(6) FOR THE SCHEDULED IMPLANT. THERE WAS A 2-3 HOUR SURGICAL DELAY DUE TO THE DELIVERY ERROR. HOWEVER, THE PATIENT RECEIVED THEIR FULL PRESCRIBED DOSE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8425323 ↗MalfunctionMay 3, 2018Inadequate Instructions for Healthcare Professional; Inadequate Instructions for Healthcare Professional; Incorrect Device Or Component Shipped
IT WAS REPORTED THAT THE FACILITY RECEIVED SEEDS WITH PRODUCT CODE (B)(4) (SALES ORDER (B)(4)) THAT WERE INTENDED FOR A DIFFERENT FACILITY, INSTEAD OF THE SEEDS THAT WERE ORDERED (1251CSR AND 1251CSRA - SALES ORDER (B)(4)). THE INITIAL INVESTIGATION INTO THE ISSUE INDICATES THAT THE FEDEX LABELS ON THE OUTER SHIPPING BOXES WERE SWITCHED. THE SEEDS THAT THE FACILITY RECEIVED ((B)(4)) WERE REPORTEDLY USED ON THE PATIENT AND THE PATIENT RECEIVED THE CORRECT DOSAGE WITHOUT IMPACT.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 7485823 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K093663. One submission often covers many models, so check the product and lot details in each record.
- Z-1702-2018 · Apr 10, 2018 · TerminatedBARD BrachySource Iodine125 radioactive seeds consist of a welded titanium capsule containing the I125 absorbed onto a nickel / copper-coated, gold-cored aluminum wire (reference F
Other Source, brachytherapy, radionuclide devices
- QuickLink™, SourceLink™ 70302QC10Bard Brachytherapy, Inc. · Source, brachytherapy, radionuclide10 reports
- QuickLink™, SourceLink™ 70303QC20Bard Brachytherapy, Inc. · Source, brachytherapy, radionuclide7 reports
- QuickLink™, BrachySource™ 1251QCSBard Brachytherapy, Inc. · Source, brachytherapy, radionuclide5 reports
- GammaTile™ GT-001Gt Medical Technologies, Inc. · Source, Brachytherapy, Radionuclide5 reports
- BrachySource™ PS1251LSBard Brachytherapy, Inc. · Source, brachytherapy, radionuclide4 reports
- QuickLink™, BrachySource™ 1251QCLBard Brachytherapy, Inc. · Source, brachytherapy, radionuclide4 reports
- BrachySource™ PS1251CSBard Brachytherapy, Inc. · Source, brachytherapy, radionuclide3 reports
- TheraSeed®, SourceCap™ TS200CSFBard Brachytherapy, Inc. · Source, brachytherapy, radionuclide3 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.